F-18 FDG PET/CT in Staging of Renal Cell Carcinoma Arising from a Native Kidney with Liver and Bone Metastasis in a Renal Transplant Recipient

Authors

  • Koramadai Karuppusamy Kamaleshwaran Department of Nuclear Medicine, PET/CT and Radionuclide therapy, Kovai Medical center and Hospital Limited, Coimbatore-641014
  • Stuart More Division of Nuclear Medicine, Department of Radiation Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town
  • Raghi Paramben Jose Department of Nuclear Medicine, PET/CT and Radionuclide therapy, Kovai Medical center and Hospital Limited, Coimbatore-641014
  • Ajit Sugunan Shinto Department of Nuclear Medicine, PET/CT and Radionuclide therapy, Kovai Medical center and Hospital Limited, Coimbatore-641014

Keywords:

RCC, Renal transplant, Native kidney, F-18 FDG PET/CT.

Abstract

Abstract: Renal cell Carcinoma (RCC) of the native kidney accounts for less than 5% of all malignancies found in transplant recipients. Owing to the rarity of this condition, there are only a number of documented case reports of patients who have undergone renal transplantation with RCC of the native kidney. Fluorine -18 Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/ computer tomography (CT) (F-18 FDG PET/CT) is used in the staging of high risk RCC or when conventional imaging is equivocal. The prognosis of metastatic RCC is poor .We report the first case of a 55 year old post renal transplant recipient diagnosed with RCC of the native kidney with liver and bone metastases imaged using F- 18 FDG PET/CT.

Published

2018-03-30

Issue

Section

Articles